TNDM - Tandem Diabetes Care Inc Stock Price, Fair Value and News

$35.77-1.63 (-4.36%)

Delayed as of 30 Dec 2024, 11:01 am ET

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

TNDM Price Action

Last 7 days

10.0%

Last 30 days

19.1%

Last 90 days

-19.5%

Trailing 12 Months

22.3%

TNDM RSI Chart

TNDM Valuation

Market Cap

2.5B

Price/Earnings (Trailing)

-19.37

Price/Sales (Trailing)

2.88

EV/EBITDA

-24.97

Price/Free Cashflow

-163

TNDM Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

TNDM Fundamentals

TNDM Revenue

Revenue (TTM)

854.4M

Rev. Growth (Yr)

31.43%

Rev. Growth (Qtr)

9.94%

TNDM Earnings

Earnings (TTM)

-126.8M

Earnings Growth (Yr)

29.46%

Earnings Growth (Qtr)

24.54%

TNDM Profitability

EBT Margin

-14.42%

Return on Equity

-53.33%

Return on Assets

-13.24%

Free Cashflow Yield

-0.61%

TNDM Investor Care

Shares Dilution (1Y)

0.72%

Diluted EPS (TTM)

-1.93

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	770.0M	796.0M	854.4M	0
2023	794.7M	790.3M	771.4M	747.7M
2022	737.7M	765.8M	790.7M	801.2M
2021	541.9M	604.8M	660.9M	702.8M
2020	394.2M	410.2M	439.2M	498.8M
2019	222.6M	281.7M	330.1M	362.3M
2018	115.9M	128.7M	148.0M	183.9M
2017	83.2M	81.5M	96.2M	107.6M
2016	80.6M	87.9M	84.5M	84.2M
2015	54.0M	59.4M	61.6M	72.8M
2014	31.6M	36.3M	42.1M	49.7M
2013	9.1M	15.7M	22.4M	29.0M
2012	0	0	0	2.5M

Get all data in R, Python etc through our Historical Stock Data APIs

About Tandem Diabetes Care Inc

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. It has development and commercialization agreements with Dexcom, Inc. and Abbott Laboratories. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

CEO	Mr. John F. Sheridan
WEBSITE	tandemdiabetes.com
SECTOR	Healthcare
INDUSTRY	Medical Devices
EMPLOYEES	2600

Tandem Diabetes Care Inc Frequently Asked Questions

What is the ticker symbol for Tandem Diabetes Care Inc? What does TNDM stand for in stocks?

TNDM is the stock ticker symbol of Tandem Diabetes Care Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Tandem Diabetes Care Inc (TNDM)?

As of Thu Dec 26 2024, market cap of Tandem Diabetes Care Inc is 2.46 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of TNDM stock?

You can check TNDM's fair value in chart for subscribers.

Is Tandem Diabetes Care Inc a good stock to buy?

The fair value guage provides a quick view whether TNDM is over valued or under valued. Whether Tandem Diabetes Care Inc is cheap or expensive depends on the assumptions which impact Tandem Diabetes Care Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for TNDM.

What is Tandem Diabetes Care Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Dec 26 2024, TNDM's PE ratio (Price to Earnings) is -19.37 and Price to Sales (PS) ratio is 2.88. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. TNDM PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Tandem Diabetes Care Inc's stock?

In the past 10 years, Tandem Diabetes Care Inc has provided -0.121 (multiply by 100 for percentage) rate of return.